A Single Arm, Simon's 2-stage Minimax Design, Phase II Open Label Trial to Investigate the Efficacy and Safety of Intra-dermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Phase of Trial: Phase II
Latest Information Update: 27 Oct 2016
At a glance
- Drugs Etanercept (Primary)
- Indications Discoid lupus erythematosus
- Focus Therapeutic Use
- Acronyms TARGET-DLE
- 04 Feb 2016 Planned End Date changed from 1 Nov 2017 to 1 Dec 2017 as reported by ClinicalTrials.gov record.
- 04 Feb 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Aug 2017 as reported by ClinicalTrials.gov record.
- 04 Feb 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.